Breaking News

Cryoport, Monash IVF Ink Multi-Year Supply Chain Solutions Agreement

Will utilize Cryoport’s cryogenic logistics solutions and ISO-certified risk mitigation process for the delivery of patients’ reproductive materials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cryoport, Inc., a global provider of products and services to the cell and gene therapy industry, signed a new three-year supply chain solutions agreement with Monash IVF Group Ltd., a provider of assisted reproductive services, as well as specialist women’s imaging and diagnostic services in Australia and Southeast Asia.   Monash IVF has more than 100 locations across Australia. Through this multi-year agreement, Monash IVF and its operating businesses will utilize Cryoport’s cryogenic logist...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters